Back to Newsroom

Ocata Therapeutics to Present at the Jefferies 2015 Global Healthcare Conference

MARLBOROUGH, Mass.– Ocata Therapeutics, Inc. (“Ocata”; NASDAQ: OCAT), a leader in the field of regenerative ophthalmology, today announced that Paul Wotton, Ph.D., President and Chief Executive Officer, will present a company overview at the Jefferies 2015 Global Healthcare Conference on Monday, June 1, 2015 at 2:00 p.m. EDT in New York City.

Click here to read more